The new joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.
President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of… Read More »Public health, racial equity, climate action drive Biden’s budget requests for healthcare
Amylyx’s ALS drug met the goals of a mid-stage study, paving the way for regulatory submissions in Europe and Canada. But the FDA is requiring data from a larger Phase 3 clinical trial and that study is slated to begin later this year.
Digital health startup Omada is adding virtual consultations with physicians to its platform. To start, the company is offering physician-guided care for diabetes and hypertension.
Livongo’s founder has created a new care navigation venture because he believes that both the experience that people undergo as they look for care and the level of risk that vendors are willing to take when they work with self-insured employers leave much to be… Read More »In MedCity Pivot podcast, Glen Tullman says other care navigation firms aren’t really taking risks
Research conducted by the Cleveland Clinic and Massachusetts-based startup Health Data Analytics Institute (HDAI) measured the difference in mortality during the pandemic between people covered by Medicare in long-term care facilities and in the community. While a Covid-19 diagnosis increased deaths in both settings, there… Read More »Cleveland Clinic researchers measure pandemic’s effect on Medicare population
In order to gain insight into how organizations are thinking about digitizing medical documents and the strategy behind those decisions, we’re conducting a brief survey of the MedCity News audience and will publish a report based on this survey’s findings.
There should be a discussion about how to address the disproportionate impact Covid-19 has had on Black communities.
Tango Therapeutics’ SPAC merger will infuse the biotech with $353 million to fund clinical trials for its cancer drugs based on synthetic lethality. Tango’s lead program is on track to reach the clinic next year.
Mayo Clinic struck joint ventures with two startups to develop and commercialize AI diagnostic tools. It’s part of a broader plan by Mayo Clinic to develop more AI tools to support clinical decisions.
In a review of 130 FDA-cleared AI tools, researchers found that the vast majority of them relied on retrospective studies. Most of the developers also didn’t share information on how many sites the algorithms had been tested in, or how they performed in different patient… Read More »FDA-cleared AI devices lack critical information on performance, equity
As part of its ongoing effort to improve maternal outcomes in the country, the government has approved Illinois’ request to extend full Medicaid coverage for new mothers. The approval extends the coverage from 60 days to one year and will give about 2,500 women living… Read More »Illinois first state to offer full Medicaid benefits to women one year postpartum
Blood clots found in six people given Johnson & Johnson’s Covid-19 vaccine have led federal health officials to recommend a pause on dosing with that shot. A CDC advisory committee on vaccine practices is meeting Wednesday to review the cases, which so appear similar cases… Read More »FDA & CDC “pause” J&J Covid-19 vaccine to launch inquiry into rare blood clot cases
Though the price transparency rule aims to make it easier for healthcare consumers to compare prices, there is a lack of standardization in how hospitals present the data, making it hard for consumers to shop around for care, a new analysis shows.
Surgical retractor systems, catheters, minimally invasive surgery, wireless power transfer technology, microwave ablation, and jaundice treatment are among the areas the six medical device finalists cover.
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
No matter if Democrats or Republicans are running the show in Washington, here are three solid bets for pharma companies to plan for in the changing drug-pricing landscape
With two cancer programs already making progress, Repertoire Immune Medicines will use the Series B financing to expand its immune synapse research to autoimmune disorders and infectious disease. CEO John Cox said his startup’s approach could advance immune medicines beyond the scope of currently available… Read More »Biotech startup Repertoire adds $189M to expand array of immune medicines
Covid-19 was a lightning rod for life science deals last year. What investment trends are taking shape in 2021? [Sponsored]
Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with investment trends focused on pain points amplified by the Covid-19 pandemic, from diagnostics development to supply chain management.
Cohere Health raised $36 million in a Series B funding round less than two years after its inception. It will use the new funds to expand its prior authorization platform and integrate health plan benefits to eliminate missed opportunities for care.
Though the number of merger and acquisition deals in the first quarter of 2021 fell below historical averages, the size of the deals was far bigger than the same period last year, a new report from Kaufman Hall shows. The total transacted revenue was $8.8… Read More »Report: Fewer health system M&A deals in Q1 2021 offset by larger transactions
Canvas Medical, a startup looking to build electronic medical records and ancillary tools for primary care systems, raised $17 million in funding.
A Regeneron Pharmaceuticals antibody cocktail currently authorized for treating Covid-19 now has additional clinical data showing it reduces the risk of infection spread. The drug developer, along with partner Roche, plan to ask regulators to expand the drug’s authorization to include disease prevention.
Microsoft will buy up healthcare AI partner Nuance for $19.7 billion. Nuance makes speech-recognition tools for clinical documentation, as well as security tools.
Historically, providers had to meet certain criteria and address three key areas in the patient’s progress notes: patient history, physical exam and medical decision making. CMS has eliminated the history and exam components as required elements for billing purposes, so medical decision making is now… Read More »How CMS final rule will impact E/M coding and documentation requirements
The HHS’ new interoperability and information blocking rules have been in effect for one week, yet how they will be enforced is unclear. But there are some clues that could provide a glimpse into what the enforcement landscape might look like, and the best thing… Read More »Enforcement landscape for HHS data-sharing rules is hazy, experts say
Digital health startup Better Therapeutics plans to go public through a SPAC merger that would value it at $187 million. The company is currently running a pivotal study to see if its app-based program could be used as a treatment for type 2 diabetes.
Sanofi, which already has messenger RNA R&D alliances with other companies, paid $160 million up front to acquire preclinical startup Tidal Therapeutics. The pharma giant said Tidal’s mRNA approach could lead to an off-the-shelf CAR-T therapy.
Fitbit is launching a trial to see if its its newest smartwatch could use pulse arrival time to measure blood pressure. Other wearable companies have tried to add wrist-based blood pressure features to their devices, but so far, they have limited accuracy.
Several healthcare entities that used Accellion’s file transfer software now find themselves the victims of a data breach, including Trinity Health. The software had vulnerabilities that were exploited by cybercriminals, resulting in the exposure of personal health information.
The public markets welcomed VectivBio and Reneo Pharmaceuticals, which priced their IPOs late Thursday. Both clinical-stage companies are developing drugs that address rare diseases.
Creating the simplest process for informed consent benefits the potential participant by allowing them the time and resources to understand fully what they are consenting to. Through eConsent processes, research also opens the door to a more diverse population to engage in trials.
Representatives from five health services startups will present their companies to three judges, followed by a Q&A. The judges for the health services track include: Cheryl Chang of BlueRun Ventures; Keith Figlioli of LRVHealth, and Steve Tolle of HLM Venture Partners.
Though a majority of healthcare workers believe that the pandemic is at least somewhat under control now, about half still feel anxious or burned out when going to work, a new survey shows. Pandemic-related stress has also given rise to physical issues among healthcare workers,… Read More »Poll: About half of healthcare workers feel burned out, anxious when going to work
Global investment firm KKR plans to acquire a majority stake in health software company Therapy Brands. PSG, a previous investor in the company, will remain a minority shareholder.
RA Capital led Ventus Therapeutics’ Series B financing, which the startup will use to develop its pipeline of medicines for “undruggable” disease targets. CEO Marcelo Bigal said the cash also gives Ventus the flexibility to consider an IPO.
As Covid-19 cases started escalating last April, providers in hotspot states, like New York, California and Washington, had to quickly pivot their IT plans. These are some of the decisions that five health IT leaders made — aside from expanding telehealth — that helped their… Read More »The key IT decisions that helped providers survive April 2020
VillageMD, a primary care startup that has Walgreens as a big backer, is reportedly planning to go public. The company has plans to open hundreds of co-located primary care clinics at Walgreens pharmacies.
Mobidiag offers multiplex testing, which is the ability to test for multiple pathogens from a single test sample. Hologic said the acquisition will enable the company to enter the acute care test market, which is projected to grow in a post-pandemic world.
The failure of IBM’s marketing-first approach to clinical AI was entirely predictable, but it didn’t have to be this way. Here’s how AI can be implemented effectively.
If we don’t prioritize solutions now, the healthcare digital divide may present more widespread national and international challenges.
The conference highlights the intersections of technology and life sciences through the prism of precision medicine. The topics at the conference span pediatric innovation in precision medicine, how tech companies are addressing clinical trial challenges, supply chain management, and more.
Virtual primary care startup Firefly Health plans to launch a benefit plan after raising $40 million in new funding. The company currently offers virtual and in-person access to a primary care team.
A European Medicines Agency review concluded AstraZeneca’s Covid-19 vaccine may be linked to cases of blood clots. The regulator directed the company to conduct more studies to learn more but stopped short of recommending other vaccines as alternatives.
Centene has rebutted the accusations made in a sealed lawsuit filed by the Ohio attorney general that accused the insurer of over-billing the state’s Medicaid department. The lawsuit is based on a misunderstanding of how Medicaid billing operates and should be unsealed, Centene said.
Akili Interactive received FDA clearance last year for its game-based digital therapeutic to be used as a treatment for ADHD. Now, the company is testing it to see if it could help people experiencing cognitive dysfunction after Covid-19.
Nonprofit hospitals get substantial tax subsidies with the expectation that they will provide higher levels of charity care to needy patients. But these hospitals spend less on charity care than their for-profit counterparts, a new analysis shows.
Finalists for the diagnostics track at INVEST Pitch Perfect include tests for upper respiratory infections, breast cancer screening, in vitro cellular immunoassays, dysphagia diagnostics, and neuroscience.
We can expect the introduction of novel and groundbreaking technologies that will immensely benefit both the dentists and the patients over the years.
While the Covid-19 pandemic has strained the healthcare industry, this administration has the advantage of being able to leverage everything we have learned over the past year to advance the next generation of value-based care.
RA Capital led the $100 million Series B round of funding for Icosavax, a startup developing vaccines based on virus-like particles. The biotech is preparing for clinical tests of vaccines for respiratory syncytial virus, human metapneumovirus, and SARS-CoV-2.
The drugmaker struck a collaboration agreement with Mass General to use its platform for heart failure and asthma management. The health system plans to launch two pilots of the digital health platform.
Insurance technology startup Bright Health has purchased Zipnosis, which provides telehealth services. Though details of the new transaction are sparse, the acquisition aims to lower healthcare costs and expand access to quality care.
Volastra Therapeutics is developing drugs for cancer metastasis, the cause of the vast majority of cancer deaths. The startup has $44 million in funding and an R&D partnership with Microsoft to develop new digital tools to detect and predict metastasis.
Vaccine hesitancy is still a challenge to providers’ immunization plans. Florida-based AdventHealth is bringing the might of AI technology — specifically machine learning and natural language processing — to combat the issue.
Nadine Peters, chief legal officer of Cota Healthcare, shares her journey to leadership in health data privacy law and policy recommendations for the Biden Administration on achieving health equity through data use and education.
The agency said it had received more than 450 reports of infections or other issues in the last four years from reprocessed urological endoscopes, which are used to view or access the urinary tract. Three patient deaths were associated with these infections.
A group of healthcare stakeholders in Oregon signed a compact that aims to spread advanced value-based payment models across the state. Though it is not legally binding, the agreement sets a target to tie 70% of healthcare payments to value within the next four years.
FDA approval of Supernus Pharmaceuticals drug Qelbree gives attention-deficit hyperactivity disorder patients another treatment option that is not classified as a Schedule II substance. It’s a different formulation of a drug that was first approved in Europe decades ago.
After going public through a SPAC merger last year, SOC Telemed bought acute telemedicine provider Access Physicians for $194 million. The deal is expected to bolster the company’s specialty consults and telemedicine services for hospitals.
U.S. Anesthesia Partners has filed lawsuits against UnitedHealthcare in Colorado and Texas, accusing the payer of forcing it out of network and intentionally interfering with its relationships with providers in those states. But, according to UnitedHealthcare, the lawsuits are an attempt to get the insurer… Read More »Lawsuit: Like a “boa constrictor,” UnitedHealthcare squeezed anesthesia group out of competition
The FDA’s rejection of Nuplazid cited clinical trial results in subgroups of patients. Acadia Pharmaceuticals said the FDA’s decision goes against all feedback the company previously received and amounts to an incorrect way of evaluating dementia patients.
Medical payments platform Inbox Health raised $15 million in series A funding. The company works with third-party billing companies to better communicate with patients and make bills clearer.
AI has already shown tremendous promise for everything from automating patient communication and non-clinical administrative tasks to reducing physician burnout. But realizing that promise more broadly requires AI developers to establish trust with their healthcare users.
Your administration needs to establish a mandate requiring health systems that have data sharing capabilities to share their Covid-19 data in the next eight months. This includes Covid-19 test results, vaccination information, and other critical data.
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says its approach could also have applications in other disorders.
As the pandemic rages on, the other major public health crisis in recent history has not ebbed. The opioid epidemic is worsening, but providers have kept their eye on the ball and are continuing their efforts to treat opioid use disorder and curb unnecessary prescriptions.… Read More »How providers are tackling a crisis within a crisis — the opioid epidemic
The deadline for ONC’s final rule on interoperability and information blocking is upon us. The time is past due for health providers, networks, and vendors to evolve their IT infrastructure — and the cloud really is the only way forward.
Dr. Thomas Van Gilder, Walmart’s first chief medical officer, will leave the company in May. Walmart’s head of dentistry, Dr. Roshan Parikh, also left the company. Both had a role in helping design some of the first clinics for Walmart Health.
Insurance startup Bright Health is reportedly planning to raise up to $1 billion in an IPO that will be launched in the second quarter of 2021. The company, which provides several insurance products as well as an IT platform, could be valued at more than… Read More »Report: Bright Health eyes $1B IPO
The Food and Drug Administration gave an emergency use authorization to two more over-the-counter Covid-19 tests that can be used without a prescription. They include Abbott’s BinaxNow test and an at-home test developed by Quidel Corp.
Companies focusing on cancer care, high-risk patients, patient safety, tele-dermatology, mental health and medical billing are among the six finalists.
The FDA increased the maximum number of doses permitted for each vial of Moderna’s Covid-19 vaccine, a change intended to make more doses available. The regulator also authorized storage changes for the vaccines at vaccination sites.
The pandemic has upended virtually every industry, and although many of the impacts are undeniably devastating, negative events can also offer opportunities for positive change, by highlighting existing problems and eliminating roadblocks to new solutions.
Healthcare is becoming increasingly unaffordable, with 18% of Americans saying in a new survey that they would not be able to afford the care they need. Respondents also reported cutting back on other expenses to afford healthcare, including money spent on food and utilities.
IQVIA has acquired Quest Diagnostics’ minority stake in Q2 Solutions, a central laboratory services joint venture the two companies formed in 2015. But Quest will remain a preferred provider of lab testing services under an agreement with Q2.
Though telehealth will continue to account for a large portion of healthcare IT budgets in 2021, there are other technology-based services driving provider interest. These range from cloud deployment to vaccine scheduling solutions as providers navigate the new landscape created by the Covid-19 pandemic.
The two companies plan to open a clinic in Phoenix this fall, and additional locations over the next five years. To start, Tia will offer virtual care services in Phoenix.
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.
The FDA decision for Tyvaso as a treatment for pulmonary arterial hypertension in patients who have interstitial lung disease is the second approval for the United Therapeutics drug. The additional indication gives the company another way to grow revenue for the drug, which faces generic… Read More »United Therapeutics notches another FDA approval for lung drug
The Achilles Therapeutics IPO comes as several other biotechs make progress developing a type of cancer immunotherapy called a tumor-infiltrating lymphocyte. Clinical-stage Achilles contends its approach could best them all.
The HHS’ information blocking rule goes into effect Monday, and for nearly a year, providers and IT vendors have been racing to prepare. But they have faced several hurdles along the way, including figuring out how to handle scenarios that could make them non-compliant.
The startup, which provides primary care services to Medicaid patients, plans to use the funds to expand into new states and add maternity and pediatrics services lines. It also recently launched a vaccination site in conjunction with the New York Department of Health.
Austin-based software startup Docstation is working to make it easier for pharmacists to strike agreements with physicians that would allow them to provide more patient care. It recently raised $3.1 million in seed funding.
Why start with innovation? Because it’s where the products, tools, solutions, and ideas that will change the status quo are born. Without diversity of thought, experience, and perspective, the end result of innovation only serves those already at the table.
Based on the efficacy and safety data for their Covid-19 vaccine in younger teens, Pfizer and BioNTech plan to ask regulators to expand emergency authorization to include this younger group. The expansion could make the mRNA vaccine available to this age group in time for… Read More »Pfizer & BioNTech report Covid-19 vaccine shows 100% efficacy in kids 12 to 15
With the emergence of smart and connected devices and technologies, CROs and life sciences organizations are able to more easily perform decentralized, virtual clinical trials. Now, industry leaders are on a mission to make the practice of administering decentralized clinical trials the norm.
To maximize patient access to care, policies should be modernized to enable the broader digital health landscape
Only with proper coverage and access to the modern technologies that made their mark during Covid-19 can we truly democratize healthcare and make the promise of digital health available to all.
The family of Dr. Lorna Breen, an emergency physician working on the front lines of the pandemic who died of suicide, is working with Congress to introduce legislation that would make it easier for phyiscians to seek out mental healthcare. At the state level, licensing… Read More »Family of Dr. Lorna Breen pushes for mental health protections for physicians
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees with the regulator’s position and will oppose the FTC’s challenge.
Medicare Advantage beneficiaries spend $1,640 less per year on healthcare than those enrolled in traditional fee-for-service Medicare plans, a new report shows. But, despite the difference in savings, satisfaction levels for both types of plans are similar.
Healthcare information exchanges could provide the missing link between providers, payers and community-based organizations working to address social determinants of health. Efforts in Nebraska and Ohio show the ways in which HIEs could advance care coordination and interoperability.
Merck agreed to pay $215 million up front to acquire Alydia Health, a startup that has commercialized a medical device that controls bleeding during childbirth. That product will join the portfolio of Merck spinout company Organon.
Now that trials can happen nearly anywhere, privacy teams and lawyers need to understand how data is collected, stored, managed, disseminated, and ultimately, archived or deleted.
Omega Therapeutics has raised more than $210 million in the past eight months for R&D of medicines that regulate genes. The company’s lead therapeutic candidate addresses a validated but elusive cancer target.
BrightInsight, a startup developing infrastructure to make it easier for companies to make their own health apps, raised $101 million in funding. General Catalyst led the series C round.
The healthcare provider and technology giant have entered into a 10-year partnership that will leverage AI, cloud and quantum computing capabilities to accelerate research. The collaboration will include the first private-sector installation of the IBM Quantum System One.
Crossover Health, a startup offering primary care services for several big tech companies, including Amazon and LinkedIn, raised $168 million in funding.
Evidation, launched as a research app where people can opt into virtual clinical trials, plans to turn some of those insights into digital health programs. The company recently raised $153 million in new funding.
The Washington-based health system has filed a lawsuit against EHR giant Cerner saying it intentionally misrepresented its products and services. Cerner’s systems did not operate as promised, leading to severe cash collection issues at Astria Health and forcing it into bankruptcy in 2019, the suit… Read More »Lawsuit: Cerner systems’ failure drove Astria Health into bankruptcy
UniQure is making a case for lifting a clinical hold on its hemophilia B gene therapy, reporting Monday results of an independent investigation that appear to clear the experimental treatment as the cause of a patient’s cancer.
The FDA has approved a Bristol Myers Squibb cell therapy made by engineering a patient’s immune cells to target a cancer protein called BCMA. The regulatory decision for Abecma in multiple myeloma gives BMS its second approved CAR-T therapy.
A group of inventors at the University of Cincinnati are developing a drone that can be used to conduct virtual visits in patients’ homes. The technology aims to fill the gap in telehealth delivery among those who do not have access to the necessary devices… Read More »Drone in your home? Telehealth makeover underway at Univ of Cincinnati
Contactless check-in is not a new concept. Many consumer-focused industries, such as hospitality, have been utilizing this technology for years — including mobile check-in and checkout, keyless entry, and more — to enhance the guest experience.
Earlier this year, AppliedVR shared results of a pivotal study that it plans to submit to the FDA. It received a breakthrough device designation last year to use its VR platform to treat fibromyalgia and lower back pain.
Regenerative medicine might someday provide replacement organs for transplant patients. But Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine, explained how the technology is already helping in the discovery and testing of drugs.
Advocate Aurora Health has launched a subsidiary focused on making investments in companies that enhance health and wellbeing. The subsidiary has already made its first move, leading a $25 million funding round for a telenutrition provider.
As Amazon starts to roll out its telehealth and pharmacy offerings, most big health systems and insurers don’t yet view it as a threat. But pharmacy benefit managers and vertically integrated payers will be keeping a watchful eye on the company as it starts to… Read More »With telehealth, pharmacy offerings, Amazon starts to encroach on PBMs
Design Therapeutics raised $240 million in the biggest biotech IPO this week. One other rare disease drug developer went public along with two oncology biotechs as the IPO momentum continues.
With the increased reliance on digital technologies, pharma companies’ outreach to healthcare providers needs to be thoughtful, efficient, and respectful. An AI-driven, omnichannel strategy makes this possible by giving every member of customer-facing teams visibility across communications.
Bristol Myers Squibb SVP Ho Sung Cho highlights legacy and ongoing research in protein degradation [Sponsored]
Cho discusses Bristol Myers Squibb’s research efforts in the field of protein degradation to advance potential treatments for a broad range of diseases. In a recent MedCity Pivot Podcast, he also shared insights on his approach to drug discovery, perspectives on dealing with failure, and… Read More »Bristol Myers Squibb SVP Ho Sung Cho highlights legacy and ongoing research in protein degradation [Sponsored]
Read new developments on healthcare startups such as Seven Bridges, Scipher Medicine, Applied VR and more.
A top executive at Chicago-based Loretto Hospital has resigned after controversy surrounding vaccination events held at businesses with close ties to him. Mayor Lori Lightfoot said an independent investigation needs to be conducted.
Founded by scientists behind the technology used in Johnson & Johnson’s Covid-19 vaccine, Leyden Laboratories is developing intranasal medicines intended to stop viruses before they infect the lungs. SARs-CoV-2 is one target, but the startup plans to address many respiratory pathogens.
Tuberculosis is highly infectious and a global problem that Covid-19 has only made worse. Ironically, two legacies of our response to Covid-19 can give us hope. Many health systems now have unprecedentedly large testing and tracing infrastructures that we can use to test for TB.
A new report from the HHS’ Office of Inspector General lays bare the varied challenges hospitals faced in the past year — and continue to face. These range from challenges in healthcare delivery to staffing shortages to shaky finances.
After a busy year, at-home testing company Everlywell is growing through two acquisitions. It bought telehealth practice PWNHealth and another at-home lab testing company.
California Attorney General Xavier Becerra may have won a narrow confirmation to be the Department of Health and Human Services Secretary, but if his past is any indication, his agenda will be bold when it comes to reining in pharma companies, boosting the Affordable Care… Read More »The “biggest thorn in President Trump’s side” is now HHS Secretary. What’s next?
AstraZeneca’s latest efficacy data for its Covid-19 vaccine are down slightly from the 79% it previously reported. The most recent data will form the basis of an application for emergency use authorization, which the company still expects to file with the FDA in coming weeks.
Researchers are investigating whether a built-in race adjustment in spirometers could further exacerbate health disparities caused by the pandemic. The medical device is commonly used to diagnose breathing conditions.
In MedCity Pivot podcast, biopharma researcher talks about protein degradation, recent success tied to Covid-19 [Sponsored]
Ho Sung Cho, senior vice president of Biodiscovery Therapeutics at Bristol Myers Squibb, talks about lessons learned from drug discovery, recent success tied to Covid-19, and how the company is leveraging its expertise in protein degradation to develop novel therapies for blood cancers, solid tumors… Read More »In MedCity Pivot podcast, biopharma researcher talks about protein degradation, recent success tied to Covid-19 [Sponsored]
The partnership between the insurer and EHR giant — announced a year and a half ago — will now focus on streamlining prior authorizations and offering providers enhanced insights about their patients. Ochsner Health will be among the first to implement the new capabilities offered… Read More »Epic-Humana partnership enters new phase focused on prior authorizations
If HIPAA does not apply to Amazon Care, then absent another privacy regulation applying, avoiding exploitation of the data relies on the good faith of the entity operating the service.
Healthcare delivery is one of the themes at the annual MedCity News virtual INVEST conference, April 19-23. Register today!
Medicare sequestration is making headlines this week, as legislation to pause the 2% payment cuts moves through Congress. Here is a recap of what the sequester cuts are, why hospitals want it gone and how lawmakers are working to make that happen.
ProQR Therapeutics has encouraging data from an early-stage study evaluating its treatment for vision loss in the rare, inherited disorder Usher syndrome. The biotech now plans to advance its RNA therapy to two pivotal studies later this year.
Ginger, a startup that connects users with mental health coaches and therapists, raised $100 million in funding. The company is shifting to a risk-based model as it expands.
GSK has terminated Moncef Slaoui as board chair of Galvani Bioelectronics after an investigation substantiated a sexual harassment claim dating to his tenure at the pharmaceutical giant. The company said the inquiry is continuing.
Becoming mired in discussions about public versus private options is not the best avenue, Instead, we can work to make Covid-related state executive orders permanent.
Appriss Health, which provides behavioral health insights to clinicians, plans to purchase care coordination solutions provider PatientPing for an undisclosed sum. The deal is expected to close within the next two months, but the combined company’s first steps are still being decided.
Areas that have been hit hardest by the Covid-19 pandemic are falling short when it comes to vaccine access. Community leaders are pushing to bring vaccination sites to their neighborhoods.
Ro, a direct-to-consumer health startup, recently raised a $500 million funding round. It plans to use the funds to expand into at-home diagnostics and care.
A new digital health company — spun out from Providence’s Digital Innovation Group — has raised $20 million in its first funding round. The company offers a platform that aims to help providers coordinate and manage digital care services.
Federal health authorities say safety observers are concerned AstraZeneca did not release complete information about the efficacy of its Covid-18 vaccine. The company responded by saying its data were from a pre-specified analysis and it will provide the most up to date efficacy data within… Read More »AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions
The emergence of new approaches to the coordination and delivery of behavioral health services is long overdue. Evaluating their impact on some of the most complex and interconnected areas of medicine will require time and work.
Healthcare must move toward a circular economy, and single-use device reprocessing offers a template to follow
In healthcare, the linear (take-make-dispose) approach to consumption is even more pronounced than in American culture in general. It’s time for change.
Interluekin-2’s use as an immunotherapy has been limited by its severe side effects. Asher Bio is developing a version of IL-2 that the startup’s Chief Technology Officer Andy Yeung said could be more targeted and safer than other approaches.
Private equity firm Accelmed recently closed an oversubscribed, $400 million fund. The firm primarily invests in health-tech startups, such as its recent investment in medication adherence company MedMinder.
Alignment Healthcare, an insurtech startup, has launched its IPO and plans to price its individual shares between $17 and $19. The company offers Medicare Advantage plans and says it uses predictive analytics technology to pinpoint seniors’ care needs.
With the extension to its Series A financing, XyloCor plans a clinical trial testing its gene therapy as an adjunct to coronary artery bypass graft surgery. A study in refractory angina is already underway.
Komodo, a data analytics startup building out information on patient encounters and outcomes, raised $220 million in funding. It plans to use the funds to build out its platform and further integrate it in users’ workflows.
AstraZeneca reported that its Covid-19 vaccine was 79% effective at preventing severe infection and 100% effective at preventing hospitalization. The company expects to file a submission seeking FDA emergency use authorization in coming weeks.
It may seem intuitive to avoid telehealth or remote care to avoid increased liability and malpractice exposure. But remote behavioral health assessment tools, real-time data-driven insights, and adaptive treatment plans are actually the things that protect clinicians from civil liability in instances of patient suicide.
The American Hospital Association is urging the Justice Department to thoroughly review UnitedHealth’s intended acquisition of Change Healthcare. The transaction would reduce competition in the health IT arena and result in higher prices and lower quality of care, the hospital group says.
The Covid-19 pandemic has decimated hospital finances, and as a result, rural providers are forced to make key IT spending decisions with limited dollars. Here is a snapshot of how they will prioritize those dollars this year and the federal support they need to survive… Read More »Rural hospitals contend with an expensive shift to digital amid shrinking margins
Automation expands the capacity of care teams, allowing providers to accomplish more with less. As a result, automation can offer an unbiased and personalized mechanism to reach patients in the manner that best suits them.
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
Scientists at The Ohio State University are developing a cell therapy intended to regrow brain tissue damaged from ischemic stroke. Results from a study in mice were published in the journal Science Advances.
Viz.AI, a San Francisco-based care coordination startup, raised $71 million in series C funding. The company plans to use the funds to build out its platform beyond coordinating care for stroke.
In an interview with MedCity News, Hospital Sisters Health System’s Director of Quality Bill Cox discussed the types of technology the 15-hospital system is using to enhance patient safety and why a systemwide strategy and culture shift is necessary for successful IT deployment.
With widespread vaccine shortages alongside continuing deaths from Covid-19, we must act now to leverage existing technology in order to improve the distribution process.
There is a growing demand for centralized care for Covid-19 long-haulers — that is, patients who had Covid-19 and recovered but continue to experience symptoms. Health systems are setting up clinics specifically for this patient population, which comes with its own set of opportunities and… Read More »Covid-19 long-hauler clinics offer a ‘medical home’ for patients on uncharted journey
Instil Bio, one of several companies developing tumor-infiltrating lymphocytes, will use its IPO cash to advance its clinical testing plans. Meanwhile, Finch Therapeutics and Gain Therapeutics also priced IPOs to fund clinical trials.
The key to addressing the impact of postpartum health on the careers of women lies in building a level of awareness to breed a level of comfort in a workforce.
The healthcare analytics company will use the funds, raised in a Series C financing round, to scale its cloud-based platform that offers providers, payers and pharma companies insights to inform business decision-making.
The agency charged the co-founders of the failed fecal microbiome startup with defrauding investors. The SEC is seeking a court order that would bar uBiome’s co-founders from serving as officers or directors, and require them to give up any ill-gotten gains.
Clinical tests of drugs from Gilead Sciences and Novo Nordisk have yielded encouraging results in nonalcoholic steatohepatitis (NASH), and the partners now want to see if the drug combinations help patients in a larger mid-stage study. The planned Phase 2b study expands on a 2019… Read More »Gilead and Novo Nordisk advance NASH collaboration to larger clinical study
Livongo Founder Glen Tullman is leading a new healthcare venture. Called Transcarent, the patient navigation platform strikes risk-sharing agreements with employers.
Aktis Oncology is developing cancer radiation treatments intended to more precise and potent compared to other radiotherapies. The startup is now out of stealth with $72 million in Series A financing.
Healthcare providers pushed to the brink after a year of the Covid-19 pandemic are tired, burned out, and even suffering the effects of Post-Traumatic Stress Disorder.
While Covid-19 requires physicians and hospitals to be more efficient than ever, a number of legal structures must be considered before providers consolidate their resources. To optimize patient care and ensure rapid payment for services, avoid running afoul of these sometimes counterintuitive regulatory schemes.
Amazon is rolling out a telehealth service for other companies to offer as an employee benefit. But scale alone will not help it to unseat well-known telehealth brands in an increasingly competitive space.
The federal price transparency rule for hospitals went into effect Jan. 1, but a new analysis shows that a majority of providers studied were “unambiguously noncompliant.”
President Joe Biden recently signed the $1.9 trillion Covid-19 relief package into law. The American Rescue Plan Act includes several provisions to boost coverage under the ACA, like widening eligibility for premium tax credits.
The Series B round of funding for University of Oxford spinout Vaccitech includes the type of financial backers that could support an IPO. While Vaccitech might be best known for its association with AstraZeneca’s Covid-19 vaccine, the startup also has programs for other infectious diseases… Read More »Oxford vaccines spinout Vaccitech raises $168M, laying groundwork for an IPO
Given our current limited supply, the threat of variant spread, and availability of higher quality antibody test kits, policymakers ought to update their vaccine guidance for those who had Covid and incorporate recent research findings on immunity and vaccine efficacy.
To reduce the systemic health inequities that have put so many individuals at higher risk of getting sick and dying from Covid-19, healthcare organizations must leverage advanced technologies such as NLP to identify SDoH and other critical information from unstructured notes.
Happify Health, a startup building digital health tools, raised $73 million in funding. The company plans to use the funds to build out more specialized solutions for health plans and pharma companies.
In another big tie-up between a telehealth and digital health company, Grand Rounds and Doctor on Demand reached a merger agreement. Grand Rounds CEO Owen Tripp will serve as CEO of the combined business.
In acquiring the two early-stage Sanofi drugs for sickle cell disease, Global Blood Therapeutics aims to complement Oxbryta, its FDA-approved treatment for the rare blood disorder. Meanwhile, Sanofi can turn its full sickle cell efforts on a gene-editing therapy partnered with Sangamo Therapeutics.
For providers and payers, a limited budget is the biggest hurdle to executing their data strategy, followed by disparate data sources and the quality of data available, according to a new survey that includes responses from 200 healthcare leaders.
Whether it is conquering the last mile in healthcare, meeting the country’s mental health crisis head-on or leveraging digital health tools effectively, trust will be central to the future of the member experience.
AstraZeneca is turning to digital technology to help patients and clinicians manage the treatment of chronic diseases. Though this technology isn’t tied to any AstraZeneca drug, the company believes such digital tools will become part of the new standard of care.
The state of California is suing Brookdale Senior Living for alleged patient safety violations at 10 nursing homes in the state and for providing false data to boost its CMS star rating. Brookdale denies both claims.
Unite Us, a New York-based technology company that makes coordination of care software, passed a $1.6 billion valuation. It build networks with local providers and works to connect members with community resources.
Telemedicine will not revolutionize health care on its own, but the experience of millions of Americans during the pandemic assures us that it will become a permanent fixture of the health care ecosystem – one likely to account for a growing share of revenue in… Read More »How can telemedicine evolve in the post-Covid era
A district judge granted preliminary approval to a settlement for a class action suit brought against HIMSS by exhibitors for its conference last year. Per the settlement, HIMSS will create a $2.8 million fund to pay back exhibitors and will credit a portion of the… Read More »HIMSS to settle class action exhibitor lawsuit for $2.8M
CMS has increased the Medicare payment rate to $40 for administering single-dose Covid-19 vaccines and $80 for two-dose vaccines. The payment increase aims to support providers as they ramp up vaccine administration.
VitalConnect’s CEO Peter Van Haur believes his company’s product not only does a great job in real time cardiac remote monitoring but also has something larger competitors lack: the ability to monitor other vital signs
Melinta Therapeutics already sells an antibiotic for serious skin infections. But FDA approval of Kimyrsa gives clinicians another option to offer patients, one with more convenient dosing.
The Ohio attorney general has filed a lawsuit alleging that a Centene subsidiary, which provides Medicaid services in the state, hired multiple companies to administer pharmacy benefits in order to inflate costs. As a result, the state’s Medicaid department paid millions in overcharges.
While telehealth use soared last year, the biggest increases were among adults living in metropolitan areas with low poverty levels, according to research published in the American Journal of Preventive Medicine.
While Covid-19 temporarily paused our ability to interact face-to-face, it also ushered in an era of global collaboration and the ability for life science teams to make decisions based on an expanded viewpoint.
Roche already sells a Covid-19 diagnostic. In acquiring GenMark Diagnostics for $1.8B, Roche is adding technology that can detect SARS-CoV-2 along with multiple respiratory diseases in a single test from a single patient sample—a capability the Swiss multinational company does not currently offer.
The past year has taught everyone the value of a more compassionate and non-punitive approach toward just about everything. Now, it’s time for leaders to take that approach and apply it, with supportive data and knowledge, to mitigating opioid addiction in their communities.
Paying close attention to social determinants of health, like ability to drive or proximity to a grocery store, can also help predict who is at highest risk of being food insecure which, in turn, can help a plan know which resources to offer to those… Read More »Increasing food security and healthy habits in your member base during Covid-19
Grifols’s acquisition of GigaGen comes as the startup’s Covid-19 antibody drug is set to start Phase 1 testing. Barcelona-based Grifols says GigaGen’s technology could also help it expand to engineered antibody therapies.
Digital health startup Cognoa shared results of a Phase 2 trial of its device, intended to treat Alzheimer’s disease using gamma frequency light and sound. Based on the results, it plans to launch a pivotal study of the treatment.
Covid-19 will continue to illuminate the behavioral health crisis, but effective use of digital solutions can drive clinical innovation and expand access to care.
Prometheus Biosciences is taking a precision medicine approach to developing drugs and diagnostics for inflammatory bowel disease. The IPO cash will fund support its pipeline of IBD drug candidates for specific patient subpopulations.
In an address on Thursday, President Joe Biden directed states to make all adults eligible for the Covid-19 vaccine no later than May 1. To get there, the Administration is buying more doses, and ramping up more vaccination sites in partnership with local clinics and… Read More »Biden directs states to make all adults eligible for vaccine by May
Many people complain about the government – probably with good reason – but the policies surrounding non-dilutive life science R&D are policies that deserve praise, and are the ones that all politicians and leaders, no matter their party affiliation, will support.
When leveraged properly, technology can decrease administrative overhead and processes both before and after care through scheduling appointments, managing patient communications, billing patients, and collecting payments.
Read new developments from Serimmune, Allelica, ForSight Robotics, Owlet Baby Care Inc., and Ascension Ventures.
In two pivotal studies years apart, Aveo Oncology’s drug tivozanib did not help kidney cancer patients live longer overall compared to the standard of care. The FDA approved still approved it, the latest development in a long saga that includes several regulatory stumbles.
The companies now have a total of 17 primary care clinics, which are currently limited to Amazon employees. It’s a separate effort from the telehealth service Amazon rolled out earlier for its Washington employees.
Sutter would pay $575 million, and would have to limit out-of-network costs and cease “all-or-nothing” contracting with health plans, according to the settlement.
With its ability to extend care into the home for all patients, including high-risk and high-acuity patients, and provide a data-first approach to healthcare, this next generation of RPM holds the key to reshaping the health care system into one that will work better for patients and… Read More »Why the next generation of remote patient monitoring holds the key to a new model of care delivery
The positive data for the antibody drug from Vir Biotechnology and GlaxoSmithKline give a clearer picture of how and when these treatments could help. Last week, a different pivotal study testing the same drug in hospitalized patients yielded murkier results.
The days of the primary care provider (PCP) acting as a gatekeeper to care for Millennials are gone. Some 85% of previous generations elected a PCP, while 45% of 18 to 29-year-olds and 28% of 30 to 49 year-olds have no primary care provider
A vaccine communication playbook developed by WELL™ Health offers guidance to providers on how to meet the communication challenges to ensure patients get both doses of the Covid-19 vaccine.
The inclusion of AI-powered patient analytics within remote patient monitoring systems addresses the need for actionable insight by stratifying continuous patient data that helps in making decisions.
Across the county, large health systems and hospitals are expanding their services to include chiropractic doctors, acupuncturists and massage therapists aimed at supporting their staff.
Forward, a concierge primary care startup, raised $225 million in funding. The San Francisco-based company plans to use the funds to expand to additional markets.
Microsoft’s latest eBook offers a look at how technology can help organizations meet patients’ changing expectations and provide personalized care.
Eli Lilly reported data from a second group in a Phase 3 study testing its combination antibody drug for Covid-19 showing that the treatment reduced the risk of hospitalization and death by 87%. That’s better than the data that supported the emergency authorization that the… Read More »Eli Lilly’s authorized Covid-19 antibody racks up more positive Phase 3 data
Covid-19 has highlighted the critical importance of increased communication and transparency between acute and post-acute providers, and the immediate need for more diverse acute and post-acute care options.
Nick Desai, the co-founder and CEO of Heal, announced he would step down on Tuesday. Scott Vertrees, an advisor to the company, will become the company’s new CEO.
Bluebird bio said independent analyses found that the gene therapy inserted its payload at a site not known to cause cancer. Based on the results, the company has asked the FDA for permission to resume all of the clinical trials that were placed on hold… Read More »Bluebird analysis finds gene therapy ‘very unlikely’ to be cause of patient’s cancer
Learn how Bright MD’s platform can help transform and deliver quality care for hundreds of low-acuity conditions in just minutes.
Rather than having multiple digital ledgers for the industry, better health care results require a single global blockchain that massively scales, capable of efficiently handling high volumes of data to act as the single source for information.
Cedar, a healthcare finance technology company, saw its valuation jump to $3.2 billion after raising $200 million in a Series D funding round. It plans to use the new funds to expand patient touchpoints and build out new use cases.
Fast growing UK telehealth provider Babylon Health bought a California-based practice as it looks to expand in the U.S. The company has several large contracts, including one to provide telehealth services to the U.K’s National Health Service.
The solution is clear, the need is urgent, and the infrastructure is in place. Send in the troops.
PatientPoint is combining with Outcome Health, which experienced a swift and sharp downfall after its former executives defrauded its clients. Together, they will form a new patient engagement company called PatientPoint Health Technologies that could be valued at $600 million.
While Covid has made many aspects of living with a rare disease more difficult, it has inspired policies and techniques that could help rare disease research progress more smoothly both during and after the pandemic.
The digital physical therapy company acquired a startup making a small, adhesive device that use electrical pulses for pain treatment.
In a lawsuit filed three years ago, Aetna alleged that Mednax had overbilled for medical procedures and services. Now, the insurer is accusing the medical group of destroying evidence pertaining to the suit and has asked a federal court to sanction Mednax.
Takeda Pharmaceutical and Maverick Therapeutics have been R&D partners since 2017. In buying out its partner, Takeda acquires technology and drug candidates that could offer advantages compared to CAR-T therapies, including the potential to treat solid tumors.
Like much U.S. primetime television, the broadcast of Oprah’s interview of Meghan Markle and Prince Harry carried a lot of pharma advertising. The sheer volume of those ads surprised many British viewers and also highlighted the volume of spending on the U.S. marketing of medicines.
Blue Cross and Blue Shield of Minnesota has filed a class-action lawsuit — on behalf of itself and insurers from 30-plus states — against Martin Shkreli and Vyera Pharmaceuticals. The suit alleges the defendants intentionally monopolized the market for Daraprim to raise the price of… Read More »Insurers sue ‘pharma bro’ Martin Shkreli, company for alleged price gouging
Insurance startup Alignment Healthcare filed preliminary paperwork with the Securities and Exchange Commission to go public. It’s another healthcare startup that is banking on the value of its technology in an IPO.
After Livongo sold to Teladoc last year, the company’s former president, Dr. Jennifer Schneider, is starting a new chapter on Cityblock’s board of directors. In an interview with MedCity News, she shared more about why she joined Cityblock and lessons learned during her time at… Read More »Top digital health exec’s advice to startups: Once you think you “know” you’ve lost the game
Blockbuster Roche drug Tecentriq will be pulled from the U.S. market as a bladder cancer treatment—three years after failing clinical tests required to stay on the market. The voluntary withdrawal comes amid an industry-wide FDA review of drugs that were awarded accelerated approval but later… Read More »Roche withdraws Tecentriq for bladder cancer, pullback comes amid FDA review
The rise in cybercrime is a significant concern among healthcare stakeholders. But defending against these types of attacks is not as complicated as it is often made out to be and can be narrowed to two key steps: deploying multi-factor authentication and staff training.
FDA approval for Yescarta in follicular lymphoma makes it the first approved CAR-T treatment for this type of cancer. It also marks Gilead Sciences’ third approved indication for a CAR-T cell therapy.
Abbott announced the launch of the newly-approved NeuroSphere Virtual Clinic by which deep brain stimulation patients can have their devices programmed and reset remotely, from the comfort of their homes without having to travel to a specialist.
Satsuma Pharmaceuticals executives say they now understand why their intranasal migraine treatment failed a pivotal test. But even with a new Phase 3 plan, the company is behind a competitor that could launch its intranasal migraine treatment later this year.
While 2020 incited widespread adoption of video-based consultations, the healthcare ecosystem is now presented with a new mandate of delivering virtual care at scale. Fortunately, there are some companies up to the task.
In a wide-ranging interview, UAB Health System CIO Joan Hicks shared some of the projects on her list for the year ahead, and how remote work has affected her team as well as IT hiring prospects in Alabama.
While addiction treatment has traditionally focused on the removal of substance use ‘symptoms’ by collecting urine samples and screening for substance use, the complexity of the biopsychosocial framework requires commensurate measurement tooling.
As the Biden Administration pushes to offer more over-the-counter Covid-19 tests, the Food and Drug Administration authorized the first molecular Covid-19 test for over-the counter use. The test was developed by San Diego-based startup Cue Health.
A group of healthcare stakeholders — Amazon Care, Intermountain Healthcare and Ascension, to name a few — has created an alliance to advocate for home-based care services through policy changes.
Several California counties and Washington state dropped One Medical as a partner in distributing vaccines after reports that it let people who weren’t eligible for the vaccine jump the line. A House panel is also launching an investigation into the company’s practices.
The pandemic has led pharma marketers to embrace digital marketing communications and the benefits of investing in telehealth platforms to engage physicians are numerous and provide a tremendous opportunity.
Antibody therapies from Brii Biosciences and Vir Biotechnology failed to show sufficient efficacy to advance to the next stage of an NIH-sponsored Covid-19 clinical trial. Apellis Pharmaceuticals and Durect also stopped work on experimental Covid treatments.
Throughout my career, I’ve had the privilege of being involved in the education of hundreds […]
This week, read new developments at Carrum Health, Seven Bridges, CARISMA Therapeutics, and more.
Members of America’s Health Insurance Plans and the Blue Cross Blue Shield Association are launching an initiative to help seniors in underserved communities get access to the Covid-19 vaccine. They aim to get 2 million Americans, older than 65, vaccinated.
The acquisition brings Amgen a novel Phase 3-ready drug for gastric cancers. For Five Prime Therapeutics, the deal is a lifeline following a series of clinical and financial setbacks that left much of the biotech’s fortunes resting on its lead antibody drug.
A new startup has entered the highly competitive insurtech market — with $50 million in new funds. Circulo, co-founded by Olive CEO Sean Lane, is a Medicaid managed care company that plans to build a platform to improve care delivery and member experience.
While half of benefits executives said their mental health coverage was adequate, more than half of employees with a diagnosable condition didn’t receive mental health treatment in the last year, according to a recent survey conducted by mental health startup Lyra Health.
The U.S. Supreme Court heard oral arguments Monday on the constitutionality of the Patent Trial and Appeal Board, an essential piece of the United States patent litigation puzzle and favored tool of generic and biosimilar patent challengers since its formation in 2012.
Hillrom axed plans to acquire cardiac monitoring company Bardy Diagnostics over reimbursement changes by a Medicare contractor. Bardy filed suit against Hillrom on Sunday.
A Brainstorm Cell Therapeutics therapy for Lou Gehrig’s disease failed a pivotal study, but the company points to better results in a subgroup. The FDA took the unusual step of publicly stating that study’s results do not show the stem cell therapy helps patients.
DispatchHealth, a startup offering at-home care, raised $200 million in funding. The Denver-based company plans to use it to expand to additional states.
In a wide-ranging interview, a senior attorney at the state Health Department discusses the national pandemic response, the need to work across the aisle, and lessons learned during a clerkship in Israel.
Takeda Pharmaceutical gains full rights to a small molecule that has shown promise treating seizures in several rare forms of epilepsy. Meanwhile, Ovid Therapeutics gains cash to support its pipeline of neurological disease drug candidates.